Last edition
News about "Mair Therapeutics "
Mair Therapeutics and Radboud University Partner to Advance Parkinson's Therapy
Mair Therapeutics has entered into a scientific collaboration with Radboud University to advance the development of TMEM175 agonists for Parkinson’s disease, with Dr Marijn Kuijpers’ laboratory at the Donders Centre for Neuroscience evaluating a portfolio of TMEM175-targeting compounds developed by the company.
Mair Therapeutics | 27/01/2026 | By News Bureau | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members